ClinicalTrials.Veeva

Menu

Combined Fractional CO2 Laser With Topical Tioconazole Versus Q-switched Nd:YAG Laser in the Treatment of Onychomycosis; a Randomized Controlled Trial

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Enrolling
Phase 4

Conditions

Onychomycosis of Fingernail

Treatments

Drug: Topical tioconazole

Study type

Interventional

Funder types

Other

Identifiers

NCT05999474
Kasr Alainy

Details and patient eligibility

About

Our aim is to assess the clinical efficacy and the safety of fractional CO2 laser combined with topical tioconazole versus Q-switched Nd:YAG laser in the treatment of OM.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • • Age group >18 years.

    • Patients of both genders.
    • Patients with OM any type.

Exclusion criteria

  • • Pregnancy

    • Localized bacterial infection around the affected nail
    • Concomitant nails disease that causes nail dystrophy or discoloration such as psoriasis, lichen planus and atopic dermatitis that may interfere with diagnosis and treatment
    • Hypersensitivity to terbinafine
    • Intake of oral antifungal medication within the last 3 months or used topical antifungal medication within the last 2 weeks prior to the laser treatment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

Fractional CO2 laser combined with topical tioconazole
Experimental group
Description:
Fractional CO2 laser (10,600 nm) will be done. The sessions will be done every 2 weeks. Topical tioconazole 28% nail solution will be applied in between the sessions twice daily
Treatment:
Drug: Topical tioconazole
Q switched ND-Yag
Active Comparator group
Description:
Laser protocol with a specific parameters will be applied on the affected nails. In one session two passes across each nail plate will be performed with two minutes pauses between each pass. Sessions will be done every 2 weeks
Treatment:
Drug: Topical tioconazole

Trial contacts and locations

1

Loading...

Central trial contact

Amira Elbendary, MD; Khadiga Sayed, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems